Byungil Kim

Years Active: 2019-2024
Publications (10 Years): 5

Vanderbilt University School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vanderbilt University School of Medicine Jun 15 2015

United States

Postdoc :: Biochemistry

Washington University in Saint Louis Sep 01 2013 - May 31 2015

United States

Postdoc :: Pathology & Immunology

Publications

Yujeong Jung, Soo Bin Ahn, Taeyang An, Hyeon-Min Cha, Minjae Kim, Hyunjin Cheon, Yejin Jang, Haemi Lee, Byungil Kim, Meehyein Kim, Yan Lee
A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectrum Anti-influenza Agents. ACS central science 10 (8) (2024)
Yujeong Jung, Soo Bin Ahn, Taeyang An, Hyeon-Min Cha, Minjae Kim, Hyunjin Cheon, Yejin Jang, Haemi Lee, Byungil Kim, Meehyein Kim, Yan Lee
A Novel Prodrug Strategy Based on Reversibly Degradable Guanidine Imides for High Oral Bioavailability and Prolonged Pharmacokinetics of Broad-Spectrum Anti-influenza Agents. ACS central science 10 (8) (2024)
Yuri Seo, Yejin Jang, Seon-Gyeong Lee, Joon Ho Rhlee, Sukyeong Kong, Thi Tuyet Hanh Vo, Myung Hun Kim, Myoung Kyu Lee, Byungil Kim, Sung You Hong, Meehyein Kim, Joo-Yong Lee, Kyungjae Myung
A dual inhibitor of PIP5K1C and PIKfyve prevents SARS-CoV-2 entry into cells. Experimental & molecular medicine (2024)
Byungil Kim, Sarah Arcos, Katherine Rothamel, Manuel Ascano
Viral crosslinking and solid-phase purification enables discovery of ribonucleoprotein complexes on incoming RNA virus genomes. Nature protocols 16 (1) (2020)
Caroline Wiser, Byungil Kim, Manuel Ascano
G3BP1 enhances cytoplasmic DNA pattern recognition. Nature immunology 20 (1) (2019)

Byungil Kim.css-eqlu8i{font-size:small;padding-left:4px;}